NCT00036114已完成3 期
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 40
研究概览
简要总结
The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 55 Years 至 95 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Institutionalized patients with Alzheimer's
排除标准
- 未提供
研究者
研究点 (40)
Loading locations...
相似试验
已完成
3 期
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeAlzheimer DiseaseNCT00041678Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
3 期
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar DisorderBipolar DisorderNCT00036101Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
3 期
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar DisorderBipolar I DisorderNCT00046384Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
3 期
Study of Aripiprazole in Patients With a History of Bipolar DisorderBipolar DisorderNCT00036348Otsuka Pharmaceutical Development & Commercialization, Inc.
尚未招募
不适用
To study therapeutic efficacy of aripiprazole augmentation in treatment resistant obsessive compulsive disorderCTRI/2021/04/032524GMC medical college